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cells and to prevent development of
steroidogenic cells with adrenal
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Abstract
Background: The interstitium of the mouse testis contains Leydig cells and a small number of steroidogenic cells
with adrenal characteristics which may be derived from the fetal adrenal during development or may be a normal
subset of the developing fetal Leydig cells. Currently it is not known what regulates development and/or
proliferation of this sub-population of steroidogenic cells in the mouse testis. Androgen receptors (AR) are essential
for normal testicular function and in this study we have examined the role of the AR in regulating interstitial cell
development.
Results: Using a mouse model which lacks gonadotropins and AR (hpg.ARKO), stimulation of luteinising hormone
receptors in vivo with human chorionic gonadotropin (hCG) caused a marked increase in adrenal cell transcripts/
protein in a group of testicular interstitial cells. hCG also induced testicular transcripts associated with basic
steroidogenic function in these mice but had no effect on adult Leydig cell-specific transcript levels. In hpg mice
with functional AR, treatment with hCG induced Leydig cell-specific function and had no effect on adrenal
transcript levels. Examination of mice with cell-specific AR deletion and knockdown of AR in a mouse Leydig cell
line suggests that AR in the Leydig cells are likely to regulate these effects.
Conclusions: This study shows that in the mouse the androgen receptor is required both to prevent development
of testicular cells with adrenal characteristics and to ensure development of an adult Leydig cell phenotype.
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Background
The two major steroidogenic cell types in the male are
the adrenocortical cell and the testicular Leydig cell.
Both cell types share a basic steroidogenic cell pheno-
type typified by expression of proteins such as CYP11A1,
STAR and HSD3B with added expression of cell-specific
enzymes such as CYP11B1 (required for corticosterone
production in adrenocortical cells) or HSD17B3 (re-
quired for testosterone production in adult Leydig cells).
Embryonic stem cells, mesenchymal cells or fibroblasts
can be induced towards a steroidogenic lineage [1–3]
and the transformed cells will follow an adrenocortical
or Leydig cell lineage or take on the phenotype of the
more basic steroidogenic cell [1, 4, 5]. Leydig cells and
adrenocortical cells are closely linked, therefore, and
there is evidence that the two cell types originate from a
single cell population [6]. While many of the factors in-
volved in steroid cell differentiation are known [7], it is
not clear what controls the final phenotype that the cells
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will adopt, although the local environment is likely to
make a major contribution.
During fetal development the adrenals and testes form
from a single adreno-gonadal primordium [6] which
functionally divides in the mouse at about embryonic
day (e) 11.5 [8]. Following adreno-gonadal separation
the testes have been shown to contain a number of cells
with adrenal characteristics and there is evidence that
these may be derived from a cohort of adrenal cells that
migrates to the developing gonad and remains there
after adrenal/gonadal separation [9]. Shortly after the
split of the adreno-gonadal primordium the fetal popula-
tion of Leydig cells develops in the testicular interstitium
and so it is also possible that some or all of the
adrenal-like cells may be a normal sub-population of the
developing Leydig cells [10–12]. After birth, between
days 7 and 10 in the mouse [13, 14], a second post-natal
or “adult” population of Leydig cells starts to differenti-
ate from progenitor cells lying mainly in the peritubular
region [15–18]. During development and in the adult,
therefore, current evidence suggests that the testicular
interstitium normally contains fetal and adult Leydig
cells and a small number of cells with adrenal charac-
teristics which are of uncertain origin [9, 19]. Devel-
opment of the adult Leydig cell population is very
largely dependent upon the action of luteinising hor-
mone (LH) but it is not clear why the testicular ad-
renal cells do not show further development since
they also respond to LH [9].
Using a number of different models of androgen re-
ceptor (AR) ablation, previous studies have shown that
AR are required for normal Leydig cell development in
the adult [19–23]. In testicular feminised (Tfm) mice,
which lack AR due to a mutation in the gene, and in
ARKO mice adult Leydig cell number is reduced by up
to 50% [20, 22] and the profile of steroidogenic enzyme
expression is markedly altered [20]. Differences in en-
zyme expression may be complex as LH levels are in-
creased in ARKO and Tfm mice [22, 24] but the results
suggest that both LH and the AR may interact to ensure
that there is normal proliferation and differentiation of
testicular steroidogenic cells and that these cells adopt a
specific Leydig cell phenotype.
To examine the role of LH and androgen in regulating
development of interstitial steroidogenic cells (both Ley-
dig cells and cells with adrenal characteristics) we have
used the hypogonadal (hpg) mouse crossed with animals
lacking ARs. Three models have been used; the hpg
mouse which lacks circulating gonadotrophins [25] and
is responsive to both LH and androgens, the
hpg.SCARKO mouse which lacks AR specifically on the
Sertoli cells and the hpg.ARKO mouse which lacks AR
ubiquitously. The testicular phenotype of these animals
has been described previously [26] and they differ from
SCARKO, ARKO and Tfm models in that they lack go-
nadotrophins. This means that the Leydig cells in all ani-
mals will be largely inactive and under-developed but
they will also be highly sensitive to the effects of exogen-
ous hormone stimulation [27–29].
Results from this study show that the AR is essential
for both LH-induced development of the adult Leydig
cell phenotype and to prevent development of cells with
adrenal characteristics in the testicular interstitium
through probable action within the Leydig cells.
Results
hCG-induced Leydig cell hyperplasia in the hpg mouse is
dependent on androgen receptors
Treatment with human chorionic gonadotropin (hCG;
homologous protein to LH that acts on the
LH-receptor) increased testicular volume (Table 1) and
caused an 8 to10-fold increase in total Leydig cell num-
ber (Fig. 1) in both hpg and hpg.SCARKO mice com-
pared to untreated animals. In hpg.ARKO mice,
treatment with hCG had no effect on testicular volume
and increased Leydig cell number by 3-fold, indicating a
requirement for androgen action to achieve the full hy-
perplastic effect of hCG (Fig. 1). All data shown as mean
± sem in Fig. 1 (and subsequent figures) are also shown
as primary raw data in Additional file 1.
Expression of transcript/proteins common to most
steroidogenic cells is unaffected by the absence of
androgen receptors
Expression of Hsd3b1 and Por transcripts was relatively
high in untreated hpg, hpg.SCARKO and hpg.ARKO
mice and showed little response to hormone treatment
(Fig. 2a). This was also reflected in the clear immunohis-
tochemical staining for HSD3B (Fig. 2b) seen in all
groups with or without hCG treatment. The main effect
of hCG was to increase the number of cells expressing
HSD3B, consistent with the total increase in Leydig cell
numbers induced by hCG, although there was some
variation in staining intensity. In contrast to Hsd3b1,
Cyp11a1 and Star transcript levels were very low in un-
treated mice but were clearly stimulated by hCG in all
three groups (Fig. 2a). Similarly, CYP11A1 was largely
undetectable by immunohistochemistry in untreated
Table 1 Effect of hCG on testicular volume
Testicular volume (mm3)
genotype control plus hCG
hpg 1.80 ± 0.16 6.12 ± 0.73*
hpg.SCARKO 1.70 ± 0.14 4.38 ± 0.12*
hpg.ARKO 0.83 ± 0.08 1.30 ± 0.06
*Significantly (P < 0.05) different to control by ANOVA and t-test
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animals from any group but showed marked interstitial
expression in all groups following hCG (Fig. 2c).
hCG induces adult Leydig cell-specific transcripts only in
the presence of androgen receptors
Transcript levels of Cyp17a1, Lhr, Hsd17b3, Insl3,
Sult1e1 and Hsd3b6, which are all Leydig cell specific
[13, 30–32], were significantly increased by treatment
with hCG in hpg and hpg.SCARKO mice. In contrast,
there was little or no effect of hCG on transcript levels
in hpg.ARKO mice (Fig. 3a). Immunohistochemical
staining for CYP17A1 showed that the protein was de-
tectable in untreated hpg, and hpg.ARKO mice (Fig. 3b)
despite low transcript levels. Following hCG treatment
there was a clear increase in the number of cells ex-
pressing CYP17A1 in the hpg mice. In hpg.ARKO mice
there was also an increase in interstitial cells expressing
CYP17A1 following hCG treatment, consistent with the
increase in Leydig cell number, but a large number of
unstained cells with a Leydig cell morphology were also
present in the interstitium (Fig. 3b, red arrows). Interest-
ingly, in the untreated hpg.ARKO mice there was clear
immunostaining of the spermatogonia (Fig. 3b, black ar-
rows). This staining was not seen in hpg mice (Fig. 3b)
or in hpg.SCARKO mice (not shown) and was largely
undetectable in the hpg.ARKO after hCG-treatment.
hCG induces adrenal transcripts/protein in a number of
interstitial cells in the absence of androgen receptors
Expression of transcripts associated with adrenocortical
steroidogenic cells (Mc2r, Cyp11b1, Cyp21a1, Akr1b7,
Mrap and Hao2) showed marked stimulation in
response to hCG in hpg.ARKO mice (Fig. 4a). In hpg
and hpg.SCARKO mice, in contrast, hCG either had no
effect on these transcripts or caused only a small in-
crease in expression (Fig. 4a). Consistent with transcript
data, CYP11B1 was undetectable by immunohistochem-
istry in control or hCG-treated hpg or hpg.SCARKO
mice (not shown). In hpg.ARKO mice occasional inter-
stitial cells stained for CYP11B1 but most were negative.
Treatment with hCG, however, led to more intense
staining although the numbers of steroidogenic cells
showing expression remained low (Fig. 4b).
AR expression in the Leydig cells inhibits development/
differentiation of cells with adrenal characteristics in the
testis
Data above show that preventing differentiation of cells
with adrenal characteristics in the testis depends on AR
expression. To determine the cell types in which AR ex-
pression is essential for this effect we examined testicu-
lar adrenal transcript levels in different cell-specific
models of AR deletion. Data in Fig. 5a shows that the
Sertoli cell AR are unlikely to be the major factor re-
sponsible for the effects seen as there was no change in
Mc2r in the SCARKO mouse, although there was an in-
crease in Cyp11b1 transcript levels in the same animals.
In contrast, there were more marked changes in both
Mc2r and Cyp11b1 in mouse models lacking AR in the
PTM cells (Fig. 5a). It is likely, however, that
PTM.ARKO and PTM.SCARKO mice also lack AR in at
least some of the Leydig cells as PTM cells are reported
to act as Leydig cell precursors [23, 33]. To test this we
examined Mc2r and Cyp11b1 transcript levels in Leydig
cell-ARKO (LCARKO) mice (which are on a different
background to the other mouse models [23, 34, 35])
(Fig. 5a). Results show that both Mc2r and Cyp11b1 are
significantly increased in testes specifically lacking AR
from Leydig cells, suggesting that the site of action of
AR necessary for Leydig cell specification (as opposed to
adrenal-like specification) is primarily the Leydig cells
themselves.
To examine, directly, the effect of AR depletion in
mouse Leydig cells we used RNAi to knockdown AR in
a mouse Leydig tumor cell (MLTC-1) line. Exposure of
MLTC-1 cells to AR miRNA significantly reduced Ar
transcript levels with or without hCG treatment (Fig. 5b)
(mean 67.5% knockdown). A reduction of Ar in these
cells was associated with a significant reduction in tran-
script levels of the LC-specific androgen target gene
Insl3 [36]. Suppression of AR also resulted in a signifi-
cant increase in the adrenal enzyme Cyp11b1 (Fig. 5b).
Discussion
During fetal development the gonads and adrenals ini-
tially form adjacent to each other from the same
Fig. 1 Treatment with hCG increases Leydig cell number in hpg,
hpg.SCARKO and hpg.ARKO mice. Adult mice were treated daily with
4 IU of hCG (or vehicle) for 1 week and Leydig cell number counted
using the optical disector method. Results show the mean ± SEM of
between 3 and 5 animals per group. Groups with different letter
superscripts are significantly (P < 0.05) different. Primary raw data are
shown in Additional file 1
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Fig. 2 hCG-induced expression of transcript/proteins common to most steroidogenic cells is unaffected by the absence of androgen receptors.
Adult hpg, hpg.SCARKO and hpg.ARKO mice were treated daily with 4 IU of hCG (or vehicle) for 1 week. a Expression of Hsd3b1, Por, Cyp11a1 and
Star was measured by qPCR and is expressed relative to Leydig cell number in each group. The presence of an asterisk (*) indicates that the
effect of hCG was significant (P < 0.05) for that mouse group relative to the respective control. b and c Immunohistochemical expression of
HSD3B and CYP11A1 in testes from hpg, hpg.SCARKO and hpg.ARKO mice with or without hCG treatment. The bar represent 50 μm. Primary raw
data are shown in Additional file 1
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priomordium and there is evidence that the same
SF1-positive cells give rise to adrenocortical cells and
fetal Leydig cells [6, 37]. Subsequently, the adrenals and
gonads separate, at about embryonic day 11 in the
mouse, and some cells from the adrenal may become as-
similated into the developing gonad [9] despite normal
inhibition of the process by WNT4 [8]. Under this sce-
nario, these cells would give rise to the adrenal-like cells
seen in the adult testis. Cells with adrenal characteristics
may also arise as a small subgroup of the developing
Leydig cells [10, 11] and it is possible that there may be
more than one such population of cells in the testicular
interstitium. Whatever their origin, these adrenal-like
cells in the mouse testis remain quiescent postnatally
and it is only in humans that they have been shown to
proliferate and to become steroidogenically active if
stimulated by high ACTH [38]. Results described here
now suggest the quiescent nature of these cells in mice
is dependent upon testicular ARs which act to inhibit
inappropriate, LH-dependent, postnatal development of
cells with adrenal characteristics. Results also show that,
in the absence of ARs, trophic stimulation of steroido-
genic cells in the testicular interstitium leads to develop-
ment of a basic steroidogenic cell type lacking enzymes
specific for the adult Leydig cells.
Data from the hpg mouse, and other models of go-
nadotrophin or LH deficiency, have shown previously
that LH is required for the establishment of a normal
population of active Leydig cells. In the absence of LH
or the LH-receptor Leydig cell number is markedly re-
duced [39–41] and Leydig cell activity is minimal [40,
41] while treatment with LH/hCG increases both cell
number and activity [27, 42, 43]. Earlier studies have
suggested that the adult hpg testis contains adult-type
Leydig cells [44] and that the main effect of LH treat-
ment is likely to be proliferation and maturation of these
cells rather than induced stem cell differentiation [44].
This is consistent with other studies which have shown
Fig. 3 Treatment with hCG induces adult Leydig cell-specific transcripts only in the presence of androgen receptors. Adult in hpg, hpg.SCARKO
and hpg.ARKO mice were treated daily with 4 IU of hCG (or vehicle) for 1 week. a Expression of Hsd3b6, Cyp17a1, Lhr, Sult1e1, Hsd17b3 and Insl3
was measured by qPCR and is expressed relative to Leydig cell number in each group. The presence of an asterisk (*) indicates that the effect of
hCG was significant (P < 0.05) relative to control for that mouse group. b Immunohistochemical expression of CYP17A1 in testes from hpg and
hpg.ARKO mice with or without hCG treatment . In control hpg.ARKO mice the blue arrows identify interstitial cells which express CYP17A1 while
the black arrows identify germ cells which express the enzyme. The red arrows indicate a number of likely Leydig cells which do not express
CYP17A1 following hCG treatment. Primary raw data are shown in Additional file 1
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increased [3H]thymidine labelling of Leydig cells in the
hpg mouse following LH treatment [27]. In addition, it is
clear from the pattern of HSD3B and CYP11A1 staining
after hCG treatment, in the current study, that there is
an overall increase in Leydig cell numbers throughout
the interstitium. This contrasts with the marked increase
in peritubular Leydig cells that occurs during Leydig
cell stem cell differentiation following ethanedimethane
sulphonate (EDS) treatment [15, 45, 46].
All steroidogenic cells express a base-line level of the
proteins CYP11A1 and STAR which are required to
form C21 steroids from cholesterol and POR is
expressed if there is further metabolism by P450 en-
zymes in the endoplasmic reticulum. HSD3B is also gen-
erally expressed in steroidogenic cells although it is
lacking in some cases (e.g. most human fetal adrenal
cells [47, 48]). The different steroidogenic cell types are
distinguished largely through the additional enzymes
Fig. 4 hCG-treatment induces adrenal transcripts/protein in the absence of androgen receptors. Adult hpg, hpg.SCARKO and hpg.ARKO mice were
treated daily with 4 IU of hCG (or vehicle) for 1 week. a Expression of Mc2r, Cyp11b1, Akr1b7, Cyp21a1, Hao2 and Mrap was measured by qPCR and
is expressed relative to Leydig cell number in each group. The presence of an asterisk (*) indicates that the effect of hCG was significant (P < 0.05)
for that mouse group relative to control. b Immunohistochemical expression of CYP11B1 in testes from hpg.ARKO mice with or without
treatment with hCG. Primary raw data are shown in Additional file 1
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Fig. 5 (See legend on next page.)
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and hormone receptors that they express. In this study,
the common steroidogenic transcripts were either
expressed constitutively in the interstitial steroidogenic
cells of the hpg or were induced by LH/hCG but, in ei-
ther case, there was no influence from the presence or
absence of ARs. This would suggest that LH/hCG acts
to induce generic steroidogenic potential in the intersti-
tial steroidogenic cells of the testis and that additional
stimulation of the ARs is essential for the induction of a
Leydig cell phenotype, consistent with previous data
from androgen-resistant Tfm and LCARKO mice [20,
23]. Both gonadal and adrenal steroidogenic cells are
dependent on SF-1 which regulates downstream expres-
sion of genes required for steroiodogenesis [49]. It has
been shown that forced expression of SF-1 in stem cells
will transform those cells into steroidogenic cells [4].
The phenotype that the transformed cells adopt is vari-
able and depends on a combination of stem cell type,
SF-1 dosage and other transcriptional factors [2–4] but,
in vivo, other factors are likely to determine the
tissue-specific cell type. The results reported here now
suggest that the AR is a required factor for generation of
the adult Leydig cell phenotype in vivo. An alternative
explanation would be that the hpg.ARKO mouse con-
tains only fetal-type Leydig cells and LH/hCG induces
proliferation and stimulates activity in these cells [50].
This would certainly be consistent with the failure of
adult Leydig cell markers to increase after hCG. Recent
studies have shown, however, that while there is a rela-
tive increase in fetal Leydig cells in the adult ARKO
mouse, adult Leydig cells still outnumber fetal Leydig
cells by a factor of about 4 to 1 [19]. Thus, lack of ARs
does not appear to prevent at least initial differentiation
and development of the adult Leydig cell population,
consistent with previous results [23].
It appears likely that the cells showing induced adrenal
transcript expression in the hpg.ARKO mice after hCG
injection are the cells with adrenal characteristics cells
described earlier [9]. This would be consistent with the
relatively small number of cells in the hpg.ARKO testes
that show an increase in adrenal enzymes in response to
hCG treatment. Overall, the failure of hCG to induce ad-
renal transcript expression in hpg mice indicates that
ARs normally inhibit trophic hormone stimulation of
cells with adrenal characteristics in the testis. Interest-
ingly, and consistent with this data, recent studies have
shown that androgens act to inhibit recruitment and dif-
ferentiation of progenitor cells into steroidogenic cells in
the mouse adrenal [51]. Relevant data has also emerged
from the study of Gata4 and Gata6 double knockout
mice. In these animals there is loss of Leydig cells [52,
53] but survival and, perhaps, proliferation of cells with
adrenal characteristics in the testis [52]. This indicates
that there may be some synergism between the ARs and
GATA factors in these interstitial cells, as seen in other
tissues [54].
Androgen receptors are expressed in the Sertoli cells,
the PTMC, vascular smooth muscle, endothelial cells
and the Leydig cells in the normal post-natal mouse
testis [26, 55] and a similar pattern of expression is seen
in hpg mice [26]. Since the effects of hormone stimula-
tion are similar in hpg and hpg.SCARKO mice, the re-
sults from this study show that androgen must mediate
its effects on Leydig/adrenal cell development either
through the cells themselves or through the PTMC, but
not through the Sertoli cells. Previous studies using the
Leydig cell specific LCARKO mouse have shown that it
recapitulates many of the effects on Leydig cell tran-
script expression seen in the ARKO mouse [23] and we
show here that there is increased adrenal transcript ex-
pression in LCARKO mice, and also when AR is specif-
ically knocked down in vitro in a Leydig cell line. This
suggests that the main effects of androgen on Leydig cell
development are mediated through ARs in the Leydig
cells. As the origin of testicular cells with adrenal char-
acteristics is uncertain, however, it is not clear whether
ARs expressed in these cells or the Leydig cells regulates
their development in the testis. Nevertheless, data from
AR knockdown in MLTC-1 cells suggests that there may
be a requirement for continued AR-mediated suppres-
sion of plasticity, since a reduction of AR in MLTC-1
cells is able to switch ‘mature’ Leydig cells towards an
adrenal cell fate.
Recent work has suggested that Hsd3b1 in the mouse
testis is only expressed in fetal Leydig cells [56] which
would suggest that the adult hpg mouse testis contains a
(See figure on previous page.)
Fig. 5 Control of adrenal cell development/differentiation in the testis depends largely on AR expressed in the Leydig cells and peritubular myoid
cells. a Testicular expression of Mc2r and Cyp11b1 in mice lacking ARs in different cell types. Transcript levels are measured relative to the external
standard (Luc). Data were analysed by single-factor ANOVA or t-test, apart from Cyp11b1 levels in SCARKO, PTM.ARKO, PTM.SCARKO mice which
was analysed initially using the Kruskal-Wallis test. The Kruskal-Wallis test showed a significant (P < 0.001) overall difference between groups which
were further analysed using single sample t-tests which showed each group was significantly different to control. Different letter superscripts
indicate differences (P < 0.05) between groups (analysed by ANOVA) while the presence of an asterisk indicates a significant difference to control
(analysed by t-test). For all data, the mean ± SEM of between 7 and 9 animals in each group is shown. b Effect of androgen receptor (AR)
knockdown on transcript levels in a Leydig tumor cell (MLTC-1) line. Cells were transfected with vehicle, lentivirus containing control, “scrambled”
miRNA or lentivirus containing miRNAs which target the Ar. Data was analysed by 2-factor ANOVA and groups with different letter superscripts
are significantly different. Each group shows the mean ± SEM of 3 or 4 individual experiments. Primary raw data are shown in Additional file 1
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significant number of fetal Leydig cells. This is consist-
ent with the “independent” nature of these cells which
do not require LH stimulation during development [57,
58] or input from the Sertoli cells [59]. Expression of
Hsd3b1 was also relatively unaffected by the presence or
absence of ARs indicating that ARs are not important
for fetal Leydig cell development, as previously sug-
gested [19].
These studies underline the importance that the ARs
play in regulating development and function of cells in
the testicular interstitium. This data, and previous stud-
ies [44], show that the interstitial tissue of the adult hpg
mouse testis contains adult Leydig cells and cells with
adrenal characteristics and that hCG/LH treatment stim-
ulates Leydig cell proliferation/activity while having little
effect on the other cells. The hpg.ARKO mouse also con-
tains adult Leydig cells and cells with adrenal character-
istics but appears to have an additional population of
“basal” steroidogenic cells. In these animals, hCG treat-
ment causes proliferation of the adult Leydig cells but
has little effect on adult Leydig cell-specific transcripts
(Fig. 3). hCG-treatment also causes the basal steroido-
genic cells to undergo proliferation and stimulation
(Figs. 2 and 3) and leads to activation of adrenal-like
cells (Fig. 4).
Conclusions
These studies have dissected the roles that LH (hCG)
and the AR play in the development of interstitial cells
in the mouse testis. As shown before, LH/hCG stimu-
lates proliferation and maturation of Leydig cells but we
show here that this process requires the presence of AR
in the Leydig cells. These AR are also required to pre-
vent activation of cells with adrenal characteristics under
LH/hCG stimulation and act, therefore, to induce the
formation of normal interstitial cell populations in the
adult mouse testis.
Methods
Animals and treatments
ARKO, SCARKO, hpg.ARKO and hpg.SCARKO mice
were generated at the University of Oxford as published
previously [16] from mice obtained originally from Prof
G Verhoeven and Dr. K De Gendt (Catholic University
of Leuven, Belgium) and from mouse colonies bred at
the University of Oxford [16]. SCARKO and ARKO mice
were produced by crossing female mice carrying an Ar
with a floxed exon 2 (Arfl) with male mice expressing
Cre under the regulation of the Sertoli cell-specific pro-
moter Amh or the ubiquitous promoter Pgk-1 [60–62].
LC-ARKO mice were generated at the University of Ed-
inburgh by mating Arfl female mice (obtained as above)
with male mice expressing Cre under the regulation of
the Fabp4 promoter (provided by Kerry McInnes,
University of Edinburgh) [23] while PTM-ARKO were
generated as previously described [34] by mating Arfl fe-
male mice with male mice expressing Cre under the
regulation of the Myh11 promoter (originally from Mi-
chael Kotlikoff (Cornell University, USA)) [35]. Mice
were killed, as necessary, by exposure to a rising concen-
tration of CO2.
Adult mice (10 weeks) were injected sub-cutaneously
with 4 IU recombinant hCG (Serono Ltd. Middlesex,
UK) in 0.2 ml PBS (phosphate buffered saline, pH 7.4,
Sigma Aldrich, Dorset, UK) once daily for 7 days. hCG
acts as an LH analog and stimulates Leydig cell function
through the LH-receptor. Mice were killed, as above, on
day 8 (24 h after the last injection) and testes snap fro-
zen in liquid N2 or fixed in Bouin’s overnight.
Stereology
For stereological analysis, testes were embedded in
Technovit 7100 resin, cut into sections (20 μm), and
stained with Harris’ hematoxylin. The total testis volume
was estimated using the Cavalieri principle [63]. The op-
tical disector technique [64] was used to count the num-
ber of Leydig cells in each testis. Leydig cells were
recognised by their position, round nucleus and rela-
tively abundant cytoplasm [39, 65]. The numerical dens-
ity of each cell type was estimated using an Olympus
BX50 microscope fitted with a motorized stage (Prior
Scientific Instruments, Cambridge, UK) and Stereologer
software (Systems Planning Analysis, Alexandria, VA,
USA). Stereological data for untreated hpg,
hpg.SCARKO and hpg.ARKO animals in this study in-
cludes data from a previous study [62] plus additional
animals. Testicular volume data (Table 1) also includes
data reported previously [26, 62] with the inclusion of
additional samples.
Immunohistochemistry
For immunohistochemistry, testes were embedded in
paraffin and sections (5 μm) were mounted on glass
slides, dewaxed, and rehydrated. Sections were incubated
with anti-CYP11A1 (rabbit polyclonal, donated by Dr.
AH Payne, Stanford University), anti-HSD3B2 (rabbit
polyclonal, donated by Prof Ian Mason, University of Ed-
inburgh), anti-CYP11B1 (mouse polyclonal, donated by
Prof Celso E. Gomez-Sanchez, University of Mississippi)
after heat-induced antigen retrieval. Bound primary anti-
body was detected using a peroxidase-conjugated sec-
ondary antibody, followed by a fluorescyl-tyramide
amplification step with visualization using 3,3-diamino-
benzidine tetrahydrochloride (Dako UK Ltd., Cam-
bridgeshire, UK). To reduce “mouse-on-mouse” effects
when using an anti-mouse second antibody blocking re-
agent (M.O.M. Vector Laboratories Ltd., Peterborough,
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UK) was used. For negative control samples,
non-immune serum replaced primary antiserum.
Cell culture and RNAi
MLTC-1 cells (mouse Leydig cell tumor, ATCC® Num-
ber: CRL-2065™) were maintained in culture at 37 °C
with 5% CO2 in 89% RPMI-1640 media (containing 2.5
mML-Glutamine, 0.5 mM Sodium pyruvate, 1.2 g/L So-
dium bicarbonate and 15mM HEPES), 10% fetal bovine
serum and 1% penicillin/streptomycin. Cells were trans-
fected with either an AR miRNA lentivirus consisting of
a CMV promoter, an mKate2 fluorescent reporter and 2
chained miRNAs that target the androgen receptor
(“Lc-cppt-CMV-mKate2-ARmiR2&4”), a ‘scrambled’
lentivirus (“Lv-cppt-CMV-mKate2-negmiRx2”) or a con-
trol with no virus. Viruses were produced by Dr. Pamela
Brown at the SURF University of Edinburgh Biomolecu-
lar Core Facility. Transfection was performed at an MOI
of 5 with medium supplemented with a final concentra-
tion of 6 μg/mL Polybrene (Sigma). Cells were then
sorted by Fluorescence Activated Cell Sorting for
mKate2 expression to increase the purity of the trans-
fected cell population before being selected for blastici-
din resistance. To treat cells with hCG, cells growing in
complete medium were allowed to reach confluence,
then replaced with serum-free medium and incubated
for four hours. The serum-free medium was then re-
moved and replaced with either serum-free medium
supplemented with 1.5 IU hCG final concentration for
“+hCG” groups or serum-free medium only for “-hCG”
groups. The cells were then incubated for 16 h before
being collected and processed for RNA extraction. Each
condition was repeated four times with two or three
flasks each time used as technical replicates.
Measurement of mRNA levels
For data shown in Figs. 1, 2, 3 and 4, testis RNA was ex-
tracted using TRIzol (Life Technologies, Paisley, UK)
and the RNA was reverse transcribed using random hex-
amers and Moloney murine leukemia virus reverse tran-
scriptase (Superscript III, Life Technologies, Paisley, UK)
as described previously [66]. To allow specific mRNA
levels to be expressed per testis and to control for the ef-
ficiency of RNA extraction, RNA degradation, and the
reverse transcription step, an external mRNA standard
was used [67, 68]. The external standard was luciferase
mRNA (Promega UK, Southampton, UK), and 1 ng was
added to each testis at the start of the RNA extraction
procedure. To measure transcript levels, real-time PCR
was used with the SYBR green method in a 96-well plate
format using an MX3000 cycler (Agilent Technologies,
Berkshire, UK). Reactions contained 5 μl 2 x SYBR mas-
termix (Agilent Technologies, Berkshire, UK), primer
(100 nM) and template in a total volume of 10 μl. At the
end of the amplification phase a melting curve analysis
was carried out on the products formed. All primers
were designed by Primer Express 2.0 (Applied Biosys-
tems, Warrington, UK) using parameters previously de-
scribed [69]. The primers used are described in
Additional file 2. Results have been normalised to ex-
pression per Leydig cell as the transcripts measured here
would be expected to be expressed specifically in ste-
roidogenic/Leydig cells and Leydig numbers in all
groups were increased by treatment with hCG.
For data presented in Fig. 5, RNA was extracted from
either whole testes or cultured cells using RNeasy Mini
kits (Qiagen Ltd., Manchester, UK). Random
hexamer-primed cDNA was prepared using the VILO
cDNA synthesis kit (Invitrogen, ThermoFisher Scientific,
Paisley, UK) according to manufacturer’s instructions.
The primers used for qPCR were designed using the on-
line Roche Universal Probe Library (UPL) software
(Roche Diagnostics Ltd., Burgess Hill, UK) and they are
listed in Additional file 2. The qPCRs were carried out
using an ABI Prism 7900 Sequence Detection System
(ThermoFisher Scientific). Transcript levels per testis
were normalised to luciferase using the ΔΔCt method
[70] as above. Transcript levels in MLTC1 cells were
normalised to an internal housekeeping gene assay for
Actb (Roche).
Statistical analysis
Data were analysed using t-tests, analysis of variance
(ANOVA) (with differences between individual groups
identified by Fisher’s post-hoc test or by t-test) or the
Kruskal-Wallis test as appropriate. Where necessary,
data were transformed using the Box-Cox method [71]
to avoid heterogeneity of variance. Statistical analysis
was carried out using Minitab v15 (Minitab Ltd., Coven-
try, UK).
Additional files
Additional file 1: Raw data from figures and tables. Primary raw data
from Figure S1-S5 and from Table S1. (XLS 73 kb)
Additional file 2: Primer sequences. Sequences of primers used for
qPCR studies. (DOCX 13 kb)
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